Schnitzer TJ, et al. Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee. ACR 2018, abstract L20.
Reumafonds teleurgesteld in advies
mrt 2017 | RA, Spondyloartritis
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE